000			03715nam a22005055i 4500
001			60503
005			20200226102514.0
007			cr nn 008mamaa
008			170809s2017 gw | s |||| 0|eng d
020			_a9783319606002 _9978-3-319-60600-2
024	7		_a10.1007/978-3-319-60600-2 _2doi
035			_a(DE-He213)978-3-319-60600-2
050		4	_aRA410-410.9
072		7	_aKCQ _2bicssc
072		7	_aBUS069000 _2bisacsh
082	0	4	_a338.473621 _223
245	1	0	_aNovel Psychoactive Substances _h[electronic resource] : _bPolicy, Economics and Drug Regulation / _cedited by Ornella Corazza, Andres Roman-Urrestarazu.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2017.
300			_aXXII, 178 p. 8 illus., 6 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_a1.The Global Emergence of NPS: An Analysis of a New Drug Trend -- 2.Legislating NPS in the European Union -- 3.Regulation as Global Drug Governance – How New is the NPS Phenomenon? -- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport -- 5.Exploring Novel Policy Responses to NPS and ‘legal highs’ in New Zealand, Poland, Republic of Ireland and the United Kingdom -- 6.Regulating NPS in the Middle East: A Critical Juncture -- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals -- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom -- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach? -- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst’s Perspective -- 11.Harmonizing NPS Legislation Across the European Union: An Utopia? -- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.
520			_aIn light of the recent emergence of New Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory measures. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and public health.
650		0	_aPharmacy.
650		0	_aHealth care management.
650		0	_aHealth services administration.
650		0	_aPublic health.
650		0	_aHealth economics.
650		0	_aMedical economics.
650	1	4	_aEconomics.
650	2	4	_aHealth economics.
650	2	4	_aPublic health.
650	2	4	_aPharmacy.
650	2	4	_aHealth care management.
700	1		_aCorazza, Ornella. _eeditor.
700	1		_aRoman-Urrestarazu, Andres. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783319605999
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-319-60600-2
912			_aZDB-2-SME
999			_c5818 _d5818